Menu
Back to Browse Journals
Biologics: Targets and Therapy
ISSN: 1177-5491
Editor-in-Chief: Dr Doris Mangiaracina Benbrook
ISSN: 1177-5475 (Print) - went to online only in 2009
An international, peer reviewed journal focusing on the patho-physiological rationale for, and clinical application of, Biologic agents and their Biosimilars in the management of autoimmune diseases, cancers, or other pathologies where a molecular target can be identified.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Indexed online:
- PubMed and PubMed Central (Biologics)
- Embase (Correct as at July 27, 2015)
- Scopus (Correct as at July 27, 2015)
- Directory of Open Access Journals (DOAJ)
- OAIster: The Open Access Initiative
Related journals you may also be interested in:
- Adolescent Health, Medicine and Therapeutics
- Biosimilars
- ChronoPhysiology and Therapy
- Clinical Interventions in Aging
- Clinical Pharmacology: Advances and Applications
- ClinicoEconomics and Outcomes Research
- Core Evidence
- Drug Design, Development and Therapy
- Drug, Healthcare and Patient Safety
- ImmunoTargets and Therapy
- Integrated Pharmacy Research and Practice
- International Journal of Nanomedicine
- Journal of Experimental Pharmacology
- Journal of Receptor, Ligand and Channel Research
- Open Access Journal of Clinical Trials
- Orphan Drugs: Research and Reviews
- Patient Preference and Adherence
- Pharmacogenomics and Personalized Medicine
- Research and Reports in Transdermal Drug Delivery
- Therapeutics and Clinical Risk Management